Intelligence

The many benefits of outsourcing stability: A Baxter-Syngene Case Study

Many Benefits of Outsourcing Stability

Discover the steps taken by Baxter and Syngene to ensure successful outsourcing of stability studies.

Pharmaceutical drug stability testing is required throughout the development cycle – from preclinical studies through to Phase 4. Stability studies can take between 2–5 years and are necessary for product approval and marketing authorization for both novel and generic drugs.

Download this whitepaper now to:

  • Unlock key learnings from this strategic partnership, including 4 practical sheets to assess critical elements of stability outsourcing based on key metricus
  • Discover the 5 key attributes considered when selecting a preferred partner in addition to infrastructure and global reach
  • Uncover 6 key training and integration initiatives implemented to achieve success
  • Understand how within 7 months of agreement sign-off Baxter and Syngene were able to commence operations in a dedicated 12,000 sq. ft. lab

Sponsored By:

Syngene Logo

Complete the form to download your whitepaper:
Pharma Intelligence UK Limited | Registered in England & Wales No. 13787459 | Suite 1, 3rd Floor | 11-12 St. James's Square | London | England | SW1Y 4LB
Privacy Policy